摘要
重型再生障碍性贫血(SAA)是免疫介导的,以骨髓造血干细胞(HSC)及造血微环境损伤、骨髓脂肪化和外周血全血细胞减少为特征的造血功能衰竭综合征。临床上表现为严重的感染、出血和贫血。目前,免疫抑制治疗(IST)与同胞供者骨髓移植(BMT)并列为SAA标准疗法。临床研究证实抗淋巴细胞球蛋白(ALG)/抗胸腺细胞球蛋白(ATG)联合环孢素(CsA)的强化IST有效率可达70%~80%。尽管如此,仍有一部分患者属IST难治或IST后复发,特别是前者,预后较差。我们对IST难治和复发SAA的研究现状作一综述。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2007年第2期137-140,共4页
Chinese Journal of Hematology
参考文献27
-
1Marsh JC.Management of acquired aplastic anaemia.Blood Rev,2005,19:143-151.
-
2Scheinberg P,Nunez O,Young NS.Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.Br J Haematol,2006,133:622-627.
-
3Rosenfeld S,Follmann D,Nunez O,et al.Antithymocyte globulin and cyclosporine for severe aplastic anaemia:association between hematologic response and long-term outcome.JAMA,2003,289:1130-1135.
-
4Frickhofen N,Heimpel H,Kaltwasser JP,et al.Antithymocyte globulin with or without cyclosporin A:11 -year follow-up of a randomized trial comparing treatments of aplastic anemia.Blood,2003,101:1236-1242.
-
5Sloand E,Kim S,Maciejewski JP,et al.Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.Blood,2002,100:1185-1191.
-
6Maciejewski JP,Follmann D,Nakamura R,et al.Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.Blood,2001,98:3513-3519.
-
7Sugimori C,Chuhjo T,Feng X,et al.Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.Blood,2006,107:1308-1314.
-
8Bacigalupo A,Bruno B,Saracco P,et al.Antilymphocyte globulin,cyclosporine,prednisolone,and granulocyte colony-stimulating factor for severe aplastic anemia:an update of the GITMO/EBMT study on100 patients.Blood,2000,95:1931-1934.
-
9Ahn MJ,Choi JH,Lee YY,et al.Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation:multicenter trial.Int J Hematol,2003,78:133-138.
-
10Maciejewski JP,Risitano AM.Aplastic anemia:management of a adult patient.ASH Edu Book,2005.110-117.
同被引文献9
-
1张宏丽(综述),郑以州(审校).重复应用ALG/ATG治疗重型再生障碍性贫血的研究现状[J].国际输血及血液学杂志,2007,30(1):58-61. 被引量:2
-
2Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for acquired severe aplastic anemia (SAA) : a prospective comparason of four different regimens. Exp Hematol, 2006; 34:826-831.
-
3Tichelli A, Passweg J, Nissen C, et al. Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol, 1998, 100:393-400.
-
4di Bona E, Rodeghiero F, Bruno B, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anemia patients unresponsive to a first course of intensive Haematol, 1999,107:330-334.
-
5Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 2003,289:1130- 1135.
-
6Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A : 11 -year follow-up of a randomized trim comparing treatments of aplastic anemia. Blood, 2003, 101: 1236-1242.
-
7Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for ac- quired severe aplastie anemia(SAA) :a prospective comparason of four different regimens [J]. Exp Hematol, 2006, 34: 826- 831.
-
8郑以州,储榆林,邵宗鸿,张益枝,陈桂彬.抗淋巴细胞球蛋白联合环孢霉素A治疗重型再生障碍性贫血的临床研究[J].中华血液学杂志,1999,20(4):175-177. 被引量:23
-
9肖海燕,刘驰,郑春梅,刘锋.二次抗淋巴细胞球蛋白/抗胸腺细胞球蛋白治疗重型再生障碍性贫血4例临床分析[J].临床血液学杂志,2011,24(3):303-306. 被引量:3
引证文献2
-
1张宏丽,井丽萍,刘永泽,史丽慧,安刚,刘晓明,孙晓明,杨舟,钱林生,郑以州.重复疗程抗胸腺细胞球蛋白治疗一例难治性重型再生障碍性贫血[J].中华血液学杂志,2007,28(10):710-712. 被引量:2
-
2王红艳,郭战冰,宋美娟,王艺兵.二次抗淋巴细胞球蛋白治疗重型再生障碍性贫血的临床观察及护理[J].护士进修杂志,2013,28(14):1270-1272. 被引量:11
二级引证文献13
-
1彭海洪.抗T淋巴细胞单克隆抗体治疗重型再生障碍性贫血的疗效观察[J].临床合理用药杂志,2014,7(14):113-113.
-
2邱艳丽,罗霞,王欣玲.二次抗淋巴细胞球蛋白治疗重型再生障碍性贫血的观察及护理[J].河北医药,2015,37(5):773-775. 被引量:3
-
3李娜,于晓娜,张美平.再生障碍性贫血患者感染的预见性护理对策探讨[J].中国保健营养,2015,25(6):146-146. 被引量:2
-
4曾艳,刘羽,谭艳丽,曾祥睿.循证护理在重组人血小板生成素治疗重型再生障碍性贫血患者中的应用[J].血栓与止血学,2016,22(2):222-223. 被引量:12
-
5郭瑞莎,张艳艳.优质护理在重型再生障碍性贫血合并感染患者中的应用效果观察[J].中外女性健康研究,2016(9):125-125. 被引量:6
-
6宁绘丽.儿童再生障碍性贫血淋巴细胞亚群及与血常规的相关性分析[J].河南医学研究,2017,26(15):2782-2783.
-
7郝静,李红霞,刘俊丽.中医护理方案在再生障碍性贫血患者临床护理中的应用[J].中华现代护理杂志,2018,24(9):1076-1078. 被引量:9
-
8方敏.康力龙治疗再生障碍性贫血的效果及其不良反应发生情况分析[J].中国医学创新,2018,15(17):133-136. 被引量:1
-
9高静.重症再生障碍性贫血感染的护理及预防[J].西部中医药,2018,31(11):108-110. 被引量:8
-
10李建平,彭广新,叶蕾,李洋,杨文睿,李园,樊慧慧,赵馨,周康,井丽萍,张莉,张凤奎.难治/复发重型再生障碍性贫血23例二次免疫抑制治疗临床分析[J].中华血液学杂志,2020,41(8):661-665. 被引量:10
-
1朱君利,常红.获得性再生障碍性贫血免疫抑制治疗[J].现代医学,2017,45(1):151-156. 被引量:2
-
2战榕,陈志哲,梁玉英,黄淑桦,吕联煌,卓光生.抗淋巴细胞球蛋白联合雄激素治疗重型再生障碍性贫血的临床研究[J].中华内科杂志,1999,38(11):781-782.
-
3蔡志梅,赵利东.国产抗淋巴细胞球蛋白联合环孢素A治疗重型再生障碍性贫血[J].实用临床医药杂志,2009,13(9):74-74. 被引量:3
-
4杨崇礼,卢学春,刘慧英.再生障碍性贫血、骨髓增生异常综合征、阵发性睡眠性血红蛋白尿症演变的问题[J].白血病,2000,9(6):367-370. 被引量:2
-
5徐文江.治疗篇再生障碍性贫血如何治疗[J].保健与生活,2013(10):5-5.
-
6张国香.抗淋巴细胞球蛋白联合环孢素A治疗重型再障的临床观察[J].长治医学院学报,2004,18(4):255-256. 被引量:2
-
7杨天楹.关于骨髓造血功能衰竭[J].中国危重病急救医学,1996,8(1):34-35. 被引量:2
-
8钮博,王卫国.再生障碍性贫血发病机制研究进展[J].蚌埠医学院学报,2009,34(12):1166-1168. 被引量:6
-
9张敬东,刘云鹏.再生障碍性贫血的诊断与治疗[J].实用乡村医生杂志,2001,8(6):1-3.
-
10沈红石,蒋复高,吴天勤,唐杰庆,李征洋,秦龙梅.两种免疫抑制疗法治疗再生障碍性贫血的细胞因子监测及疗效分析[J].东南国防医药,2006,8(5):324-327. 被引量:2